New York, New York (PRWEB) August 07, 2014
Stryker hip lawsuits (http://www.strykerhiprecallclaims.com/) alleging injury due to recalled Rejuvenate and ABG II Modular-Neck Hip Stems continue to move forward in a multicounty litigation underway in New Jersey’s Bergen County Superior Court, Bernstein Liebhard LLP reports. According to a Case Management Order issued on August 4, 2014, the Court’s ongoing mediation efforts have resulted in the resolution of two more cases. Of the 21 Stryker hip recall claims that have now undergone Phases I and II of Early Mediation, 19 have been settled. (In Re Stryker Rejuvenate Hip Stem and the ABG II Modular Hip Stem Litigation, No. 296)
The Order also reported that mediation sessions for three remaining cases slated for Phase II of the Program are in the process of being scheduled. The Court is also preparing to select 10 Stryker hip lawsuits for Phase III, and has directed the parties to submit a list of eligible cases by August 11, 2014.
“Our Firm is representing numerous clients in the Stryker hip recall litigation underway in New Jersey. We are pleased to see that these cases are moving forward,” says Bernstein Liebhard LLP, a nationwide law firm representing the victims of defective drugs and medical devices. The Firm continues to offer free legal evaluations to individuals who were allegedly harmed by Stryker’s Rejuvenate and ABG II Modular-Neck Hip Stems.
Stryker Hip Recall
The Stryker hip recall was announced by the U.S. Food & Drug Administration on July 6, 2012. Stryker has warned that fretting and corrosion of the Rejuvenate and ABG II hip stems places recipients at risk for adverse local tissue reactions, pain and swelling. In addition, the company has recommended that all patients fitted with one of these devices undergo medical testing to ensure it is working properly, even if they have not experienced any symptoms that would suggest a problem with their implant.*
Court records indicate that more than 2,000 Stryker hip lawsuits have been filed in Bergen County Superior Court since the recall was announced. All of these claims similarly allege that the defective nature of the Rejuvenate and ABG II hip stems caused recipients to suffer chronic pain, metallosis, osteolysis, tissue necrosis, and other complications that resulted in premature failure of their hip implant.
In addition to the cases pending in New Jersey, court records show that more than 900 Stryker hip recall claims that involve similar allegations have been filed in a federal multidistrict litigation underway in U.S. District Court, District of Minnesota. (In re: Stryker Rejuvenate and ABG II Hip Implant Products Liability Litigation, No. 244)
Individuals who were allegedly harmed by Rejuvenate and ABG II hip stems may be eligible to file their own Stryker hip lawsuit. To learn more about the Stryker hip recall, please visit Bernstein Liebhard LLP’s website, or call 800-511-5092 to arrange for a free, no-obligation case review.
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $3 billion on behalf of our clients. The Firm has been named by The National Law Journal to the Plaintiffs’ Hot List, recognizing the top plaintiffs firms in the country, for the past 12 consecutive years. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since it was first published in 2003.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
ATTORNEY ADVERTISING. © 2014 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Felecia L. Stern, Esq.
Bernstein Liebhard LLP